Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-03

Clinical Trial Update: Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of probucol in patients with diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probucol (Probucol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED